Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study
奥法妥木单抗联合HyperCVAD/HD-MA诱导治疗可使新诊断的套细胞淋巴瘤患者达到较高的微小残留病灶阴性率:一项II期研究的结果
期刊:Cancer
影响因子:5.1
doi:10.1002/cncr.34106
Torka, Pallawi; Akhtar, Othman S; Reddy, Nishitha M; Baysal, Bora E; Kader, Angela; Groman, Adrienne; Nichols, Jenna; Mavis, Cory; Tario, Joseph D; Block, AnneMarie W; Sait, Sheila N J; Ghione, Paola; Sundaram, Suchitra; Przespolewski, Eugene R; Mohr, Alice; Lund, Ian; Kostrewa, Jessica; McWhite, Kenneth; DeMarco, Joseph; Johnson, Michael; Darrall, Andrea; Thomas-Talley, Rosh-Neke; Wallace, Paul K; Neppalli, Vishala; Hutson, Alan; Hernandez-Ilizaliturri, Francisco J